Asthma alternative therapy hearing
This article was originally published in The Tan Sheet
Executive Summary
House Government Reform Committee hearing tentatively scheduled for July 20 to discuss complementary and alternative therapies for asthma. The meeting follows two previous hearings convened this spring by committee Chair Dan Burton (R-Ind.) that focused on FDA's collection of dietary supplement adverse events and the proposed redefinition of "disease," respectively (1"The Tan Sheet" May 31, p. 3, and 2March 29, p. 3). Confirmation of the July 20 hearing date awaits commitment from a celebrity witness